Source: http://boards.bsd.dli.mt.gov/pha
Timestamp: 2018-08-15 01:17:05
Document Index: 413891964

Matched Legal Cases: ['art 6', '§37', '§37', '§ 37', '§37', '§24', 'art 17']

Welcome to the Montana Board of Pharmacy
The Board of Pharmacy makes every effort to include on this web site all relevant information pertaining to the licensing and regulation of the following license types:
Individuals: Pharmacists, Certified Pharmacy Technicians, Pharmacy Technicians-in-Training, Interns, and Dangerous Drug Researchers.
Facilities: Community Pharmacies, Hospital/Institutional Pharmacies, Out-Of-State Mail-Order Pharmacies, Limited Service Pharmacies/Class IV Facilities, Outpatient Surgical Centers, and Wholesale Drug Distributors.
Individual License Renewal Deadline June 30, 2018
The license types listed below for individuals are in renewal starting May 2 and ending June 30, 2018. The new renewal fees per rule change are listed with each license type and a 100% late fee will be applied for those who renew late. Renewal forms are available in the “Forms” tab. To renew online, go to https://ebiz.mt.gov/POL and click on the Health Care Licensing tab. For assistance with account login, contact Unit A at 406-444-6880.
Pharmacist ($65)
MPDR Fee ($30)
Endorsement for Clinical Pharmacist Practitioner ($25)
Pharmacist Inactive ($15)
Certified Pharmacy Technician ($30)
Dangerous Drug Researcher ($100)
Wholesale Drug Distributor Licensees
All wholesale drug distributor (WDD) licensees must provide additional information as indicated on application and renewal forms to assist with future implementation of license changes pursuant to 2017 Montana legislation to comply with FDA requirements.
All supply chain entities (including wholesale distributors, third-party logistics providers (3PLs), repackagers, and manufacturers) must continue to be licenses in Montana as WDD until rules are in place to implement the new license types.
The new 2017 law increasing access to naloxone is Title 50 Chapter 32 Part 6.
Montana Department of Public Health and Human Services (DPHHS) naloxone information is available through the Opioid Overdose Prevention resources.
Montana Standing Order for Opioid Antagonists
Marcie Bough, PharmD, Executive Officer
Phone: (406) 841-2371
Phone: (406) 841-2240
Email: dlibsdmpdr@mt.gov
John Douglas, RPh, Board Inspector
Phone: (406) 431-1952 (cell)
Vacant, Board Inspector
Complaint information (information on filiing a complaint against a licensee):
Phone: (406) 841-2357
Continuing education (questions and information):
Renewal questsions, verifications to other states, address changes, and name changes:
Application or licensing questions for Pharmacist, Wholesale Drug Distributor, Out-of-State Mail-Order Pharmacy, and Dangerous Drug Researcher:
Application or licensing questions for Community Pharmacy, Institutional Pharmacy, Pharmacy Technician, Technician-in-Training, Pharmacist Intern, Limited Service Pharmacy, and Outpatient Surgical Center:
Members serve 5 year terms and may not serve more than 2 consecutive terms.
Individual Board Members can be contacted by email at dlibsdpha@mt.gov. In your message please specify which board member you would like to contact. For additional contact information and information on board member terms, please visit the Governor’s Office link for Board Members and Councils at http://boards.mt.gov/.
Starla Blank – President, Pharmacist
Rebekah Matovich – Vice President, Certified Pharmacy Technician
Marian Jensen – Secretary, Public Member
Mike Bertagnolli, Pharmacist
Paul Brand, Pharmacist
Tony King, Pharmacist
Charmell Owens, Public Member
HIPAA Info.
HIPAA Made Simple: Pharmacist's Survival Guide
Cancer Drug Respository Log
Cancer Drug Repository Donor Registry Log
NABP Montana Newsletter Home Page
To receive the Montana Newsletters electronically, please subscribe to the Montana Board of Pharmacy Newsletter Alert email list by sending an email to MontanaBoPNewsletter@nabp.net with the word “Subscribe” in the subject heading.
The Montana Board of Pharmacy News is published by the Montana Board of Pharmacy and the National Association of Boards of Pharmacy Foundation, Inc, to promote compliance of pharmacy and drug law. The opinions and views expressed in this publication do not necessarily reflect the official views, opinions, or policies of the Foundation or the Board unless expressly so stated.
The Board licenses and regulates the following individual license types in Montana: Pharmacist, Pharmacy Technician, Pharmacy Technician-in-Training, Pharmacist Intern, and Dangerous Drug Researcher.
The Board licenses and regulates the following facility license types in Montana: Certified Community Pharmacy, Certified Institutional Pharmacy, Out-of-State Mail-Order Pharmacy, Wholesale Drug Distributor, Limited Service Pharmacy (Class IV Facilities), and Outpatient Surgical Centers.
Please select a license type to the left for application and renewal information.
$70.00 Montana Application
$180.00 Transfer or Reciprocity from another State
$25.00 MPJE
$35.00 NAPLEX
$25.00 Clinical Pharmacist Practitioner
Graduated from an American Council of Pharmaceutical Education (ACPE) Accredited
School of Pharmacy and Proof of 1500 documented internship hours
C. Examination Information: Required to pass NAPLEX and MPJE
D. Renewal Period: May 1 - June 30
Late Renew Online for 45 days until Aug. 14
E. Renewal Fee: Active $65 / Late Fee $65 / Inactive $15 / Inactive Late $15
F. Continuing Education:
It is required for each renewal period1.5 CEU’s (10 hours equal one CEU) with 0.5 CEU obtained in an approved contact/group hours or 2.0 CEU if a pharmacist does not take at least 0.5 CEU in an approved contact/group program.
G. Other Special Requirements: Complete the NABP license transfer application.
Pharmacy Community - Certified
$75.00 Montana Dangerous Drug Act Dispenser Fee
$75.00 Pharmacy Technician Utilization Plan
B. Renewal Period: Oct. 1 - Nov. 30
Late Renew Online for 45 days until Jan. 14
C. Renewal Fee: Active $150 / Late fee $150
D. Other Special License Requirements:
DEA Registration required for Dispensing of Controlled Substances
Schematic of pharmacy must be submitted with application.
Pharmacy Institutional - Certified
The following outlines general registration information. For specific information on filing an application, you will need to obtain the application, which includes a detailed listing of the requirements.
A. Application Fee: All Fees are Non-Refundable $35.00
Minimum of a high school diploma or an equivalency certificate.
Pharmacy Technician certified by the Pharmacy Technician Certification Board (PTCB), Exam for the Certification of Pharmacy Tecnician (ExCPT) or other board approved certifying entity.
Pharmacy Technician-in-Training has 18 months from the time of registration to pass the Pharmacy Technician Certification Board (PTCB) or Exam for the Certification of Pharmacy Technicians (ExCPT).
E. Renewal Fee: Active $30 / Late Fee $30
D. Renewal Period Certified Technician: May 1 - June 30
E. Renewal Fee Certified Technician: Active fee $30 / Late Fee $30
A. Application Fee: $5.00 Duplicate License Fee
B. Other Special License Requirements:
Actively engaged in the practice of pharmacy for one year unless otherwise approved by the Board or other approved disciplines.
A preceptor may only supervise one student in internship or one student in Introductory Pharmacy Practice Experience (IPPE) at any time. No more than three persons can be supervised at one time (including technicians and students) unless an exception is specifically granted by the Board. A pharmacist preceptor may supervise two students at a time if the students are completing an Advanced Pharmacy Practice Experience (APPE) through an approved school of pharmacy.
Registered Intern Pharmacist
A. Application Fee: All fees are Non-Refundable $50.00
B. Education Requirements: Currently enrolled in an American Council of Pharmaceutical Education (ACPE) School of Pharmacy
C. Renewal Period: There is no renewal required. The intern registration is valid for the duration of the professional years of pharmacy school.
D. Other Special Requirements:
The “Internship Experience Affidavit” and “Evaluation of Internship Site” must be filed by the intern at the end of the internship experience, Introductory Pharmacy Practice Experience (IPPE), or Advanced Pharmacy Practice Experience (APPE) in a given site or after 500 hours, whichever comes first.
The “Advanced Pharmacy Practice Experience Affidavit” provided by the University must be filed by the intern at the end of the academic year.
$100.00 Montana Dangerous Drug Act Distribution Fee
$100.00 Montana Dangerous Drug Manufacture Fee
$75.00 Montana Medical Gas Supplier
$75.00 Montana Medical Gas Distributor
C. Renewal Fee: Active $240 / Late Fee $240
Limited Service Pharmacy
The following out lines general licensing information. For specific information on filing an application, you will need to obtain the application, which includes a detailed listing of the requirements.
A. Application Fee: $45.00
B. Renewal Period
October 1 - November 30, Late Renewal 45 days until January 14
C. Renewal Fee: Active $45 / Late Fee $45
D. Other Special License Requirements: Schematic of the pharmacy area including security.
A. Application Fee: $100.00
B. Renewal Period: Regular renewal dates: May 1 - June 30
C. Renewal Fee: Active $50 / Late Fee: $50
D. Other Special License Requirements: Resume of all research proposed relative to any dangerous drugs. Registraion for such purpose pursuant to the Federal Controlled Substances Act of 1970 (DEA).
A. Application Fee: All Fees are Non-Refundable $240.00
Registered with the Montana Secretary of State of Montana
DEA registration required for Distributor/Manufacture of Controlled Substance
DEA Registration required for Dispensing
MPDR Drug Registry
Welcome to the Montana Prescription Drug Registry (MPDR)
Click "What is the MPDR?" to learn more about this exciting patient safety program.
If you are having trouble with the MPDR search screen:
If the search screen does not respond when you enter search parameters, then please do the following:
Configure your browser to run in compatibility mode.
Close the browser completely – shut down all tabs and windows.
Re-open your browser and access the MPDR at www.mpdr.mt.gov.
If the above steps don’t resolve the problem, try installing the Firefox browser and using it to run the MPDR screens. Firefox is a free download available at http://www.mozilla.org/en-US/firefox/new/. When installing Firefox, you do not need to select it as your default browser.
These steps should resolve the issue. Ask your technical team for assistance if you don’t know how to perform any of the above steps. You can also call the MPDR’s technical team at 406-449-3468, Option 0.
MPDR Fee Collection
Each Montana licensee who is authorized to prescribe or dispense controlled substances is required to pay a $30 fee for establishing and maintaining the MPDR [§37-7-1511(1) MCA]. Collection of this fee is now integrated with Montana’s license renewal process; licensees are no longer required to submit a separate payment for the MDPR fee. Click the “How Is The Registry Funded?” link for more information.
MPDR Registered Users can now delegate their MPDR search authority to authorized agents, or Delegates. Eligible pharmacists and prescribers who have not yet completed all steps of the MPDR’s registration process cannot delegate their search authority. To become an MPDR Registered User, follow the instructions given in the white box on the MPDR’s Home Page, www.MPDR.mt.gov.
Registered Users, serving as the Supervising Provider, and their Delegates must review a new set of online training documents. This required training is posted on the MPDR’s Information Page, www.MDPRInfo.mt.gov. Responsibilities for delegating search authority are outlined.
Registered Users must create an online relationship with their Delegate(s). Each Supervising Provider is responsible for monitoring how their Delegate uses the MPDR’s online service and for updating their online relationship(s) when staffing changes occur.
Delegates will create their own MPDR login credentials (user name and password), and must identify the Supervising Provider who authorizes each of their patient history searches.
Go to the MPDR Information Page, www.MPDRInfo.mt.gov, for more information about Delegate Access.
Zero Reporting Rule Change
Pharmacies that seldom dispense controlled substances in Montana can now submit their zero reports monthly instead of weekly. Click on the “What Data Should I Submit?” link for full details about MPDR reporting requirements.
Pharmacies that never dispense controlled substances in Montana can now request to be excused form submitting any zero reports to the MPDR. Click on the “Zero Reporting Attestations” link for more information.
Veterans Administration and Indian Health Services/Tribal Health Data
The Veterans Administration (VA) facilities in Montana began submitting their new prescription data to the MPDR in April 2016, and have successfully submitted one year of historical prescription data.
Indian Health Services (IHS) and Tribal Health facilities in Montana began submitting their prescription data to the MPDR in 2014; a full three years of IHS/Tribal Health prescription history should be present in the MPDR.
Future MPDR System Enhancements, updated June 2016:
Interstate Data Sharing will facilitate the sharing of MPDR data with prescription monitoring programs in other states. This project requires the development of an interface program and modifications to the online search service that will enable an MPDR Registered User or Delegate to identify the participating states whose data they want to see in a search result. The National Association of Boards of Pharmacy’s (NABP) PMP InterConnect (PMPi) service and platform will facilitate interstate data sharing. PMPi features include a robust user-defined management console that will allow enforcement of the MPDR’s access requirements and limitations while exchanging data with other states. Currently, PMPi has 32 participating states, and several other states, including Montana, have begun the process required for participation.
Unsolicited Reporting capabilities will allow Board of Pharmacy staff to notify MPDR Registered Users of potential misuse or diversion of controlled substances based upon information in the registry. Threshold guidelines have been suggested in administrative rule, ARM 24.174.1706. Unsolicited Reporting functionality will also assist in meeting certain reporting requirements as a recipient of Harold Rogers U.S. Department of Justice grants.
The Statistical Reporting Project will include the development of additional statistical reporting and data analysis capabilities. New reports will be developed that meet all aspects of the MPDR’s overall grant-related reporting requirements; the project will also enable MPDR staff to generate de-identified data files for analysis by educational, research, and/or public information purposes.
The MPDR’s online service won a 2013 Digital Government Achievement Award (DGAA) for excellence in Government to Citizen Services. This prestigious award is for cutting-edge web development, and the MPDR program received an Honorable Mention in this highly competitive category.
The MPDR’s online service received a 2013 Information Technology (IT) Project Excellence Award from the State of Montana. These awards are given to State IT projects that demonstrate innovation, are well managed, and use IT to meet business needs in an effective and efficient manner.
This project is supported by Grant No. 15-X01-91993 awarded by the Montana Board of Crime Control (MBCC) through the Office of Justice Programs, US Department of Justice. Points of view in this document are those of the author and do not necessarily represent the official position or policies of the US Department of Justice.
MPDR Online Services
MPDR Information Page
What is the MPDR?
The 2011 Montana Legislature passed HB83, the Patient Safety Act, which created the Montana Prescription Drug Registry (MPDR). The MPDR became functional in 2012 as an online tool to provide a list of controlled substance prescriptions to health care providers to improve patient care and safety. The program may also be used to identify potential misuse, abuse and/or diversion of controlled substances.
Pharmacies are required to report to the MPDR all controlled substance Schedule II – V prescriptions within 8 days of dispensing. Generally, pharmacies are reporting weekly or daily. The MPDR has adopted a nationally-accepted standard for this type of data submission. Click “ What data should I submit?” for further details.
All information collected for the MPDR is treated as confidential, protected health information.
The MPDR’s online service offers prescribers and pharmacists the ability to search their patents’ medication history for controlled substance Schedule II – V prescriptions. These individuals can have online access to data stored in the registry providing they meet the eligibility and application requirements specified by law. Refer to “Who can access the MPDR?” for more information.
The following Montana licensees are eligible to become MPDR Registered Users: Dentists, Physicians (MD and DO), Naturopathic Physicians, Optometrists, Pharmacists, Physician Assistants, Podiatrists, Resident Physicians and Advanced Practice Registered Nurses (APRNs) with prescriptive authority.
MPDR Registered Users can identify authorized agents (Delegates) who can search the MPDR on behalf of their MPDR Supervising Provider. Pharmacists can identify Pharmacy Technicians and Pharmacy Interns as authorized agents. Prescribers can identify any staff member as an authorized agent.
All Montana licensees who are authorized to prescribe or dispense controlled substances are required to pay a $30 annual fee. Fee collection is integrated into the license renewal process. See “How Is The Registry Funded?” for full details.
What data should I submit?
What data should my Pharmacy submit to the MPDR?
All pharmacies that hold an active Montana license are required to register with the MPDR and make regular data submissions to the MPDR. This includes community pharmacies, out-of-state mail order pharmacies, outpatient surgical centers, dangerous drug researchers, and institutional pharmacies under certain circumstances. Wholesale Drug Distributors are not required to report to the MPDR. Refer to §37-7-1503 Mont. Code Ann. and Admin. Rules of Montana 24.174.1704 for full details.
All affected pharmacies are required to register and submit their historical data and begin regular weekly submissions within 30 days of being licensed to practice in Montana. Download the MPDR Reporting Guide for Pharmacies for complete instructions on how to register and submit data to the MPDR.
The MPDR adopted the American Society for Automation in Pharmacy (ASAP) Version 4.1 format for data submission, which is a nation-wide standard recognized by most pharmacy software vendors. Download the MPDR’s Technical Specifications for full details on the MPDR’s data submission standards.
A pharmacy’s first data submission should include historical data back to the effective date of their Montana license.
All Schedule II, III, IV and V controlled substances must be reported within 8 days of the date the drug was dispensed.
Note that institutional pharmacies are only required to report prescriptions that leave their premises, such as prescriptions dispensed through the Emergency Department.
Any errors, rejections or warnings that are received during a data submission must be corrected and resubmitted to the MPDR within 8 days of the original date of submission.
If the pharmacy did not dispense any controlled substances in Montana during a calendar month, the pharmacy is required to submit a “zero report” entry to the MPDR no later than the fifth calendar day of the following month.
Note that institutional pharmacies are not required to submit zero reports.
Pharmacies that never dispense controlled substances in Montana may request to be excused from submitting zero reports. Click “Zero Reporting Attestations” for more information.
Institutional Pharmacy reporting requirements:
Failure to report in a timely manner may result in disciplinary action by the Board of Pharmacy.
If a patient leaves the facility with a controlled substance in their possession, the pharmacy is required to report such dispensing within 8 days.
If the controlled substance was administered in the facility and the patient did not leave the premises with additional doses, the pharmacy is not required to report that administration.
Institutional pharmacies are not required to submit zero reports.
Zero Reporting Attestations
Can my Pharmacy be excused from submitting monthly Zero Reports?
Institutional Pharmacy licensees are not required to submit zero reports.
Wholesale Drug Distributor licensees are not required to submit any reports to the MPDR.
Any other pharmacy that never dispenses controlled substance Schedule II – V prescriptions to patients in Montana may request to be excused from zero reporting by taking the steps listed below.
IMPORTANT NOTE: Submitting a request to be excused from zero reporting does not mean that the request has been approved. The pharmacy must continue submitting monthly zero reports until they are notified via an email from the MPDR (dlibsdmpdr@mt.gov) that their request has been approved.
How to request to be excused from the MPDR’s zero reporting requirements:
Pharmacies that never dispense controlled substances to patients in Montana may request to be excused from submitting monthly zero reports by taking the following steps:
Newly-licensed pharmacies, including licenses re-issued due to ownership changes and changes of location, must register with the MPDR (see pages 7 through 11 of the MPDR Reporting Guide for Pharmacies) to obtain a Unique ID. Note that pharmacies already licensed in Montana should have an existing Unique ID and do not need to create a new registration (see page 7 of the MPDR Reporting Guide for Pharmacies).
If the pharmacy does not have a DEA registration, the pharmacy should enter a DEA number of MT9999999 during the MPDR registration process.
Make note of the Unique ID assigned after a pharmacy is registered.
Download the Pharmacy Zero Reporting Attestation Form.
The Pharmacist-in-Charge (PIC) must complete the form. A corporate office cannot submit this form on behalf of the PIC.
The PIC must include the pharmacy’s Unique ID on the request form; incomplete forms will not be considered for approval.
The original request form should be mailed to the MPDR’s address, which is provided in the Instructions section of the form. This form cannot be submitted via fax or email.
The pharmacy is not excused from monthly zero reporting until an email confirmation has been received from the MPDR (dlibsdmpdr@mt.gov), and must continue to submit timely zero reports until such notification has been received.
IMPORTANT NOTE: if an excused pharmacy subsequently dispenses a controlled substance to a patient in Montana, the pharmacy is required to report the prescription with 8 days of the date the prescription was dispensed. The pharmacy is also required meet the MPDR’s monthly Zero Reporting requirement from that date forward.
A previously-excused pharmacy is not allowed to be excused a second time from the MPDR’s Zero Reporting requirements.
The MPDR’s operating expenses and system enhancement costs are funded through a combination of fees and grants.
MPDR Fees
Each Montana licensee who is authorized to prescribe or dispense controlled substances is required to pay a $30 fee for establishing and maintaining the MPDR [§ 37-7-1511(1) MCA]. This fee is collected at the time of license renewal. Licensees who owe the MPDR fee include Dentists, Physicians, Physician Assistants, Resident Physicians, Naturopathic Physicians, Optometrists, Pharmacists, Podiatrists, and Advance Practice Registered Nurses with prescriptive authority.
Please note that payment of the MPDR fee is required from all Montana licensees who are authorized to prescribe or dispense controlled substances, regardless of the practitioner’s physical location or use of the MPDR’s online services.
In 2011, the MPDR received a grant through the Montana Board of Crime Control (MBCC) from the Federal Department of Justice (DOJ), Bureau of Justice Assistance (BJA) to cover the initial planning, start-up and operating expenses. These funds enabled the Board of Pharmacy, through the Department of Labor and Industry, to build and launch the MPDR’s core system, and the grant expired on March 31, 2014.
The MPDR received a second grant from MBCC as of October, 2013, and those funds became available for use on April 1, 2014. This grant covered some operating expenses, as well as costs incurred for education and system enhancements, and the grant expired on March 31, 2016.
The MPDR received a third grant from the MBCC in October 2015. Funds from this newest grant became available on April 1, 2016.
Click on the “Montana Prescription Drug Registry” link for a description of future MPDR system enhancements.
Who can access the MPDR?
All prescription data contained in the MPDR is protected health information.
There are no fees associated with access to information in the MPDR. Access will be granted to the types of licensees specified below.
Pharmacists, physicians and other licensees with prescriptive authority for controlled substances are eligible for online access to registry information. Montana licensees who are eligible for online access to the MPDR include Dentists, Physicians, Physician Assistants, Resident Physicians, Naturopathic Physicians, Optometrists, Pharmacists, Podiatrists, and Advance Practice Registered Nurses (APRNs) with prescriptive authority. Eligible licensees can apply for registry access on the MPDR Home Page, www.mpdr.mt.gov (follow the registration instructions and links in the white box).
Designated representatives from the Montana Medicare and Medicaid programs, Tribal Health, Indian Health Services and Veterans Affairs are eligible for online access to registry information that has been collected for participants in that representative’s program. These individuals can apply for registry access by completing a request form and submitting it to the MPDR office. The application form for access by agency representatives is available on the MPDR’s Information Page, www.MPDRInfo.mt.gov.
Law enforcement professionals, including coroners, can obtain a report of an individual’s registry information by submitting an investigative subpoena for information related to an active investigation. A subpoena must contain certain details in order for the MPDR to release protected health information. Please refer to “How Law Enforcement Can Obtain MPDR Information” on the MPDR’s Information Page, www.MPDRInfo.mt.gov, for full details. All reports will be delivered digitally through a secure online file transfer service.
Any individual can request that their medical practitioner or pharmacist provide them with a copy of their own prescription history from the MPDR.
An individual may also submit a notarized copy of a request form to the MPDR’s administrative office in order to obtain a digital or paper report of their own prescription history from the registry. The request form for individual patients is available on the MPDR’s Information Page, www.MPDRInfo.mt.gov.
State licensing boards or their agents may request a report when a licensed health care provider is under active investigation for suspected drug abuse or drug diversion. This information may only be shared with the licensing board or individuals who are otherwise involved in the investigation. Board Investigators must submit a request form to the MPDR; this form is posted on the MPDR’s Information Page, www.MPDRInfo.mt.gov. All reports will be delivered digitally through a secure online file transfer service.
Montana Board of Pharmacy staff members have access to information in the Registry for administrative and maintenance functions of the MPDR.
Refer to §37-7-1506 Mont. Code Ann. and to Administrative Rules of Montana §24.174.1708 for full details.
www.MPDR.mt.gov. This is the MPDR Home Page. All online user activity begins on this page.
www.MPDRInfo.mt.gov. This is the MPDR’s Information Page, which contains the following:
Links for Prescribers and Pharmacists to become Registered Users.
Required online training for Registered Users and their Delegates.
Links for Pharmacies include the MPDR’s Technical Specifications for Reporting, an MPDR Reporting Guide, a Fact Sheet about how to correct information previously submitted to the MPDR, and a form requesting that the pharmacy be excused from submitting zero reports to the MPDR.
Links for law enforcement include instructions on how to subpoena MPDR information and how to read the resulting MPDR Reports.
Agency links include applications for online access by agency employees and a data request form for use by licensing board investigators.
Individuals can download the required form for requesting a copy of their own MPDR history.
General Information about the MPDR and links to related statutes and rules.
Where can I find more information about the MPDR?
MPDR Home Page: go to www.mpdr.mt.gov.
Click the “Try the Demo” button at the bottom of the page.
Click the “Information” and “How Do I” links at the top of the page.
MPDR Information Page: go to www.mpdrinfo.mt.gov. The Information Page contains links to:
Required training programs for users.
Application and Request Forms.
Information Sheets and Users Guides.
For technical assistance with registry access, please contact pdrassistance@egovmt.com or 406-449-3468, Option 0.
If you still cannot find the answer to your question, please contact the MPDR office at dlibsdmpdr@mt.gov or 406-841-2240.
If you would like to be notified of rule changes, Advisory Committee meetings, and other changes pertaining to the MPDR, please send an email to dlibsdmpdr@mt.gov and request to be added to our Interested Parties List.
MPDR Advisory Group
The Board of Pharmacy has statutory authority to establish an Advisory Group responsible for providing information and advice about the development and operation of the MPDR. This group consists of representatives from various licensing boards and professional associations, as well as Tribal Health, Medicaid, Medicare, public health agencies, the Department of Justice and the legislature. Members of the advisory group serve at the pleasure of their respective appointing authorities.
Current members of the MPDR Advisory Group:
Starla Blank Advisory Group Chair, Montana Board of Pharmacy
Dave Campana Montana Medicaid Pharmacist
Dale Chamberlain Montana Board of Dentistry
Dean Chrestenson Missoula Police Department
Bill Gallea Advisory Group Co-Chair, St. Peter's Hospital, Emergency Physician
Bruce Hayward Montana Board of Medical Examiners
Corey Heffernan Montana Pharmacy Association
Kevin Howlett Confederated Salish & Kootenai Tribes
Kaelyn Kelly Office of Consumer Protection, Montana Department of Justice
Tony King Montana Pharmacy Association
Mark Long Montana Department of Justice, Division of Criminal Investigation
Joan McMahon Montana Medical Association
Ian Nesbit Montana Association of Naturopathic Physicians
Kaye Norris Montana Pain Initiative
Nancy Patterson Montana Association of Naturopathic Physicians
Trudi Schmidt Former Montana State Representative
Laureli Scribner Montana Board of Nursing
Siri Smillie Montana Governor’s Office
Kathy Sprattler Montana Board of Nursing
To contact a member of the MPDR Advisory Group, send an email to dlibsdmpdr@mt.gov. MPDR staff will forward your email to the appropriate individual.
Administrative Rules pertaining to pharmacy are written and adopted by the Board of Pharmacy. The Board writes rules in order to administer the laws over which the Legislature has given the Board authority. Rules can be changed by going through the rule-making procedure. They do not go through the Legislative process. The Board of Pharmacy continuously reviews rules to determine needed changes.
Chapter 24.174 - Board of Pharmacy
Chapter 24.101 - Business Standards Division
MONTANA ADMINISTRATIVE RULE (MAR) 24-174-70
In the matter of the amendment of ARM 24.174.501 examination for licensure as a registered pharmacist, 24.174.526 requirements to become a clinical pharmacist practitioner, 24.174.1704 requirements for submitting prescription registry information to the board, and the repeal of 24.174.2401 screening panel, 24.174.2402 complaint procedure, and 24.174.2403 legal suspension or revocation.
MONTANA ADMINISTRATIVE REGISTER (MAR) 24-174-69
In the matter of the amendment of ARM 24.174.401 fee schedule, 24.174.602 internship requirements, and 24.174.605 foreign intern requirements
MONTANA ADMINISTRATIVE REGISTER (MAR) 24-174-68
In the matter of the amendment of ARM 24.174.1712 pertaining to the prescription drug registry fee
Effective July 22, 2017
MONTANA ADMINISTRATIVE REGISTER (MAR) 24-174-67
In the matter of the amendment of ARM 24.174.501 examination for licensure as a registered pharmacist
MONTANA ADMINISTRATIVE REGISTER (MAR) 24-174-66
In the matter of the amendment of ARM 24.174.503 administration of vaccines, 24.174.1412 additions, deletions, and rescheduling of dangerous drugs, and the repeal of ARM 24.174.1420 through 24.174.1424 related to scheduling of dangerous drugs
Effective Sept. 25, 2015
MONTANA ADMINISTRATIVE REGISTER (MAR) 24-174-65
In the matter of the amendment of ARM 24.174.301 definitions, 24.174.411 pharmacist meal/rest breaks, 24.174.602 internship requirements, 24.174.701 registration requirements, 24.174.903 patient counseling, 24.174.1101 personnel, 24.174.1111 drug distribution and control, 24.174.1115 use of contingency kits, 24.174.1704 requirements for submitting prescription registry information, 24.174.2403 legal suspension or revocation, the amendment and transfer of ARM 24.174.510, 24.174.514, and 24.174.523 related to prescription requirements, 24.174.1121 sterile products, the adoption of NEW RULE I quality assurance program requirements, and the transfer of ARM 24.174.511 through 24.174.513, 24.174.515, and 24.174.520 through 24.174.522 related to prescription requirements
NOTICE OF PUBLIC HEARING ON PROPOSED AMENDMENT, AMENDMENT AND TRANSFER, ADOPTION, AND TRANSER
NOTICE OF AMENDMENT, AMENDMENT AND TRANSFER, ADOPTION, AND TRANSFER
MONTANA ADMINISTRATIVE REGISTER (MAR) 24-174-64
MONTANA ADMINISTRATIVE REGISTER (MAR) 24-174-63
In the matter of the amendment of 24.174.301 definitions, 24.174.1201 wholesale drug distributor licensing, 24.174.2107 registered pharmacist continuing education and the adoption of NEW RULES I use of contingency kits, II definitions, III information required for submission, IV electronic format required for the transmission of information, V requirements for submitting prescription registry information, VI failure to report prescription information, VII registry information review and unsolicited patient profiles, VIII access to prescription drug registry information, IX registry information retention, X advisory group, XI prescription drug registry fee, XII release of prescription drug registry information to other entities, and XIII interstate exchange of registry information
MONTANA ADMINISTRATIVE REGISTER (MAR) 24-174-62
In the matter of the amendment of ARM 24.174.301 definitions, 24.174.402 dangerous drug fee schedule, 24.174.503 administration of vaccines by pharmacists, 24.174.523 transmission of prescriptions, 24.174.1003 identification of pharmacist-in-charge, 24.174.1202 minimum information required for licensure, 24.174.1302 telepharmacy operations, 24.174.1503 acceptable cancer drugs, the adoption of NEW RULES I emergency prescription refills, II remote medication order processing services, III schedule I dangerous drugs, IV schedule II dangerous drugs, V schedule III dangerous drugs, VI schedule IV dangerous drugs, VII schedule V dangerous drugs, VIII through XVI board-established medical assistance program, XVII through XXII quality improvement program, XXIII limited service pharmacy, and the repeal of ARM 24.174.813 class IV facility
MONTANA ADMINISTRATIVE REGISTER (MAR) 24-174-61
In the matter of the amendment of ARM 24.174.303 definitions, 24.174.501 examination for licensure, 24.174.503 administration of vaccines, 24.174.510 prescription requirements, 24.174.602 internship requirements, 24.174.604 preceptor requirements, 24.174.2104 and 24.174.2106 registered pharmacist continuing education, and the repeal of ARM 24.174.1010 disciplinary action
MONTANA ADMINISTRATIVE REGISTER (MAR) 24-174-60
In the matter of the amendment of ARM 24.174.401 fee schedule, 24.174.403 change in address, 24.174.805 change of pharmacist-in-charge, 24.174.813 class IV facility, 24.174.1003 identification of pharmacist-in-charge, 24.174.1201 wholesale drug distributor, 24.174.1302 telepharmacy operations, 24.174.1412 dangerous drugs, and the adoption of NEW RULES I through X cancer drug repository, and NEW RULES XI through XIV clinical pharmacist practitioner
NOTICE AMENDMENT AND ADOPTION
MONTANA ADMINISTRATIVE REGISTER (MAR) 24-174-59
In the matter of the amendment of ARM 24.174.301 definitions, 24.174.503 administration of vaccines, 24.174.510 prescriptions, 24.174.523 transmission of prescriptions, 24.174.601 objectives, 24.174.602 internship, 24.174.701 registration requirements, 24.174.703 pharmacy technician, 24.174.817 record keeping, 24.174.1002 registration conditions, 24.174.1114 emergency drug kit, 24.174.2102 and 24.174.2103 renewal, 24.174.2301 unprofessional conduct, and repeal of 24.174.1007 agent of records
MONTANA ADMINISTRATIVE REGISTER (MAR) 24-174-58
In the matter of the proposed amendment of ARM 24.174.301 definitions, 24.174.401 fee schedule, 24.174.1122 ambulatory surgical facilities, and 24.174.2104 continuing education
Title 2 Chapter 15 Part 17 - Board of Pharmacy
Title 37 Chapter 7 - Pharmacy
Title 45 Chapter 9 - Crimes Dangerous Drugs
Title 45 Chapter 10 - Crimes Model Drug Paraphernalia Act
Title 50 Chapter 31 - Montana Food, Drug, and Cosmetic Act
Title 50 Chapter 32 - Controlled Substances (Dangerous Drugs, )
Title 50 Chapter 41 (Repealed) - Health and Safety Laetrile
Title 50 Chapter 42 - Health and Safety Dimethyl Sulfoxide (DMSO)
Title 50 Chapter 43 - Health and Safety Calicium-EAP, Harnosal, and Phosetamin
Patient Acceptance Form
Pharmacy - Facility Inventory Log Book
Pharmacy - Facility Notification to Board
Pharmacy - Facility Cancer Drug Repository Donor Registry Log
Certification of Pharmacist/Person-in-Charge Change Form
License Application Forms and Checklists
Pharmacist - Checklist
Pharmacy Institutional
Pharmacy Technician - Checklist
Pharmacy Technician-in-Training - Checklist
Pharmacy Technician Utilization Plan
Pharmacist Preceptor License
Pharmacist Intern - Checklist
Wholesale Drug Distributor - Instructions
Dangerous Drug Researcher - Checklist
Pharmacist Continuing Education Summary Form
In order to meet its mission, the Board is charged with taking appropriate action for unprofessional, incompetent, or unlawful practice. You can learn more about the complaint process or file a complaint with the Board.
For the complaint form FAQ, click here.
Alicia Tangen, Compliance Specialist
Montana Impaired Pharmacist Program (MIPP)
MIPP Helpline: (toll free) 877-748-4400
Call 406-531-4145 or fax 406-677-2915, PO Box 7307, Missoula, MT 59807, Email: mtassist@msn.com
Montana Dropbox Locations
Drugs Approved for Emergency Kits
Name changes must be requested in writing with documentation of the name change included (marriage license, divorce decree etc.). If you would like a copy of your license in your new name you must include $5 for a duplicate license.
Please use the address change form located under the forms tab on this website (or notify the board via fax or US mail). All licensees are required to notify the Board of an address change within 30 days.
The three personal character references are required to be submitted before a technician-in-training becomes certified as a technician.
A Certified Pharmacy, Wholesale Drug Distributor or a Mail Order Pharmacy is required to submit a new application if there is a change in location or a change in ownership of more than 50%. The application needs to be submitted 30 days prior to the change.
The Board must be notified in writing when 5% to 50% ownership is changed.
The Intern license shall expire not later than 12 months after the date of graduation or at the time of professional licensure, whichever comes first.
A pharmacist has to be actively engaged in the practice of pharmacy for one year, unless approved by the Board. A form is provided on the website. Proof of completion of a training course is required.
A registered pharmacist in good standing may supervise no more than three technicians at any time.
No, a pharmacist-in-charge of a Mail Order Pharmacy needs to be licensed in good standing in the state in which the Mail Order Pharmacy is located.
A Wholesale Drug Distributor needs to be licensed if business is conducted with the state of Montana.
The Board requires 1.5 CEU (15 clock hours) with a minimum of 5 hours to be obtained in an approved group setting or 2.0 CEU (20 clock hours) if you do not take at least 5 hours in an approved group program. The CEU is required within the 12 months prior to June 30 in order to renew your license. An additional 15 hours may be accumulated and applied to the following licensing year. Once approved, a course may not be used more than once to satisfy this requirement. Pharmacists renewing as a new graduate are exempt from this requirement. Pharmacists residing in another state are required to meet Montana's requirements for continuing education.
A pharmacy technician is required to maintain a current Pharmacy Technician certification for their Montana licensure. The continuing education is required by the certifying agency.
Click here for PDF of Complaint Process FAQs.